Difference between revisions of "Magnani L, et al. Proc. Natl Acad. Sci. USA (2013) cited as Ref 613 in DOI: 10.1038/s41392-020-0110-5 (Q9876)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 110, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: Page(s) (P105): E1490-E1499, #quickstatements; #temporary_batch_1590074839150) |
||
| (One intermediate revision by the same user not shown) | |||
| Property / title | |||
| + | Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer (English) | ||
| Property / title: Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | E1490-E1499 | ||
| Property / Page(s): E1490-E1499 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:47, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Magnani L, et al. Proc. Natl Acad. Sci. USA (2013) cited as Ref 613 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Magnani L
0 references
2013
0 references
Proc. Natl Acad. Sci. USA
0 references
110
0 references
Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer (English)
0 references
E1490-E1499
0 references
